Completed PHASE4 INTERVENTIONAL 2-arm NCT00147290

ADVANCE CRT - D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy (ADVANCE-CRTD)

ADVANCE CRT - D: ATP Delivery for Painless ICD Therapy

Sponsor: Medtronic Cardiac Rhythm and Heart Failure

Conditions Tachycardia, Ventricular Ventricular Fibrillation

Interventions Implantable Cardiac Defibrillator

Updated 8 times since 2017 Last updated: Jun 30, 2025 Started: Feb 29, 2004 Primary completion: Apr 30, 2007 Completion: Jan 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00147290, this PHASE4 trial focuses on Tachycardia, Ventricular and Ventricular Fibrillation and remains completed. Sponsored by Medtronic Cardiac Rhythm and Heart Failure, it has been updated 8 times since 2004, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

8 versions recorded

Aug 2025 — Present [monthly]

Completed PHASE4
Jul 2025 — Aug 2025 [monthly]

Completed PHASE4
Sep 2024 — Jul 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2022 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medtronic Cardiac Rhythm and Heart Failure

Data source: Medtronic Cardiac Rhythm and Heart Failure

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sesto San Giovanni, Italy